• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
July 29th - Despite some speculation that the Federal Reserve might unexpectedly raise interest rates on Wednesday, Fundstrat Global Advisors market strategist Tom Lee believes this is unlikely, primarily based on recent progress on inflation. The latest inflation data shows that housing costs and other key components are slowing, giving the Fed room to keep rates unchanged. Therefore, it would be surprising if the Fed, which always emphasizes data collection, concluded that inflationary pressures remain strong based solely on surface observations. Admittedly, inflation has not yet returned to 2%, but the impact of tariffs and rising oil prices are distorting these figures. However, the Fed may consider further reducing its asset holdings on its balance sheet.TSMC (TSM.N): Raw material supply is normal.On July 29th, CSPC Pharmaceutical Group (01093.HK) announced in Hong Kong that its Phase II clinical trial (SYH2062-003) for the treatment of essential hypertension in adults, developed by the Group, has been officially launched at its first center in China. This product specifically silences the angiotensinogen (AGT) gene, inhibits the expression of the corresponding protein, and alleviates excessive activation of the renin-angiotensin system (RAAS), thereby exerting an effective pathway inhibition and long-term blood pressure control effect.On July 29, CSPC Pharmaceutical Group (01093.HK) announced in Hong Kong that CRB-701 (SYS6002), which the Group licensed to Corbus Pharmaceuticals, Inc. for development, has been approved by the U.S. Food and Drug Administration to initiate a registration clinical trial (trial code: TEMPO-1) for second-line treatment of oropharyngeal squamous cell carcinoma.Italian oil company Eni: Refineries will operate at maximum capacity in the third quarter.

Forecast for the Gold Price: XAU/USD moves up above $1,850 as yields fall following FOMC minutes

Daniel Rogers

Jan 05, 2023 15:01

 48.png

 

In the late New York session, the gold price (XAU/USD) has attracted buying activity following a corrective move to approach the critical support of $1,850. After failing to sustain above $1,860.00, the precious metal declined; however, the corrective move is light and does not indicate a serious reversal.

 

After a decline in the U.S. Manufacturing PMI bolstered indications of further deceleration in the U.S. Consumer Price Index, market participants' demand for risk-perceived assets such as the S&P 500 increased (CPI). In response to a decrease in product demand, corporations may be compelled to reduce the price of factory items.

 

The US Dollar Index (DXY) fell below the 104.00 level as yields on 10-year US Treasuries were subjected to intense pressure and plummeted to roughly 3.69 percent. Safe-haven assets are under pressure due to the anticipation of a further fall in inflationary pressures. After remaining aggressive throughout the entire year, Federal Reserve (Fed) head Jerome Powell changed to a slowing scenario in December regarding an interest rate hike. Undoubtedly, the inflation rate is still a significant distance from the 2% target; yet, the presence of factors that support a further deceleration in the price index weighs on safe-haven assets.